Single agents in the second-line treatment of non-small cell lung cancer

被引：0
|
作者：
Belani, CP
机构：
[1] Univ Pittsburgh, Pittsburgh Canc Inst, Lung Canc Program, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA
来源：
SEMINARS IN ONCOLOGY | 1998年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：10 / 14
页数：5
相关论文
共 50 条
  • [21] Cisplatin combination regimen in the second-line treatment of non-small cell lung cancer
    Altundag, O.
    Mertsoylu, H.
    Akcall, Z.
    Sakalli, H.
    Ozyilkan, O.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Second-line chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
    Ardizzoni, A
    Tiseo, M
    [J]. JOURNAL OF CHEMOTHERAPY, 2004, 16 : 104 - 107
  • [23] Second-Line Chemotherapy and Beyond for Non-Small Cell Lung Cancer
    Durm, Greg
    Hanna, Nasser
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 71 - +
  • [24] Considerations for second-line therapy of non-small cell lung cancer
    Stinchcombe, Thomas E.
    Socinski, Mark A.
    [J]. ONCOLOGIST, 2008, 13 : 28 - 36
  • [25] SECOND-LINE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER
    Cullen, M.
    [J]. LUNG CANCER, 2009, 64 : S13 - S13
  • [26] Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib
    Zugazagoitia, Jon
    Diaz, Asuncion
    Jimenez, Elisabeth
    Nunez, Juan Antonio
    Iglesias, Lara
    Ponce-Aix, Santiago
    Paz-Ares, Luis
    [J]. FRONTIERS IN MEDICINE, 2017, 4
  • [27] Biweekly Vinorelbine and Gemcitabine as Second-Line Treatment and Beyond in Non-Small Cell Lung Cancer
    Chelis, L.
    Xenidis, N.
    Amarantidis, K.
    Prassopoulos, P.
    Chamalidou, E.
    Neanidis, K.
    Mikroulis, D.
    Chatzaki, E.
    Karakitsos, P.
    Kakolyris, S.
    [J]. CHEMOTHERAPY, 2010, 56 (05) : 353 - 358
  • [28] Influence of Radiotherapy in Second-Line Treatment with Immunotherapy in Patients with Non-Small Cell Lung Cancer
    Azkona, E.
    Carrera, S.
    Rubio, I.
    Mane, J. M.
    Lacambra, I.
    Sancho, A.
    Novo, E.
    Lopez-Vivanco, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S969 - S969
  • [29] Weekly docetaxel as a second-line treatment for advanced non-small cell lung cancer (NSCLC).
    García, R
    Pérez, P
    Alfonso, R
    Pérez-Manga, G
    Díaz-Rubio, E
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 116 - 116
  • [30] Second-line treatment options in advanced non-small cell lung cancer: Current status
    Cullen, M
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (01) : S3 - S8
12345